WHAT IS CHART?
When serial or subsequent COMPASS® evaluations are requested on the same patient and deemed clinically appropriate by a Genoptix Hematopathologist, Genoptix will automatically provide a CHART report, unless otherwise indicated by the ordering physician.
A CHART report is comprised of a series of COMPASS or COMPASS Select reports generated over time. It includes all medically-necessary technologies, a consultative review and correlation with relevant prior findings by a Genoptix Hematopathologist.
With a CHART evaluation, you can:
- Monitor response to therapy
- Determine disease progression
- Evaluate clonal evolution
- Assess residual disease
ONCOLOGY CONSULTATIVE SUPPORT
For COMPASS and CHART workups, Genoptix provides you access to our staff and technology expertise:
- 20+ board-certified molecular pathologists, hematopathologists and geneticists (easily accessible upon request)
- 200 trained professionals on staff at Genoptix, including PhDs, clinical laboratory scientists and pathology groups
- Advanced, comprehensive capture-based next-generation sequencing and other molecular tests